A study by IQVIA finds that first prescription rejection rates were unchanged for the first MFP negotiated drugs after implementation in January. A notable study by IQVIA found that for the first drugs subject to Medicare maximum fair price (MFP) agreements, initial rejection rates were not significantly lower than before the new prices took effect … Continue reading MFP Agreements Don’t Guarantee Better Patient Access